17 Healthcare Stocks Moving In Thursday's Pre-Market Session

Gainers

• Aurinia Pharmaceuticals, Inc. AUPH shares increased by 107.4% to $17.40 during Thursday's pre-market session. The market value of their outstanding shares is at $456.3 million. The most recent rating by Oppenheimer, on September 10, is at Outperform, with a price target of $14.00.
• ACADIA Pharmaceuticals, Inc. ACAD shares moved upwards by 16.6% to $51.65. The market cap stands at $6.5 billion. The most recent rating by Cantor Fitzgerald, on November 26, is at Overweight, with a price target of $70.00.
• DarioHealth, Inc. DRIO stock rose 7.1% to $9.30. The market cap stands at $10.7 million.
• Innate Pharma, Inc. IPHA shares rose 3.1% to $6.37. The market cap seems to be at $387.1 million.
• Genfit, Inc. GNFT shares increased by 2.7% to $16.12. The market cap stands at $552.9 million.
• Canopy Growth, Inc. CGC shares increased by 1.9% to $18.73. The market cap seems to be at $6.9 billion. According to the most recent rating by Bank of America, on November 20, the current rating is at Buy.
• Galapagos, Inc. GLPG shares moved upwards by 1.7% to $209.17. The market cap seems to be at $11.3 billion. The most recent rating by Bank of America, on December 02, is at Neutral, with a price target of $199.00.
• OPKO Health, Inc. OPK shares rose 1.2% to $1.66. The market cap seems to be at $945.1 million. The most recent rating by Piper Jaffray, on November 25, is at Overweight, with a price target of $2.50.
• Walgreens Boots Alliance, Inc. WBA stock moved upwards by 1.1% to $59.59. The market value of their outstanding shares is at $48.8 billion. The most recent rating by JP Morgan, on October 23, is at Neutral, with a price target of $63.00.

Losers

• Sage Therapeutics, Inc. SAGE shares plummeted 58.5% to $61.93 during Thursday's pre-market session. The market value of their outstanding shares is at $7.0 billion. The most recent rating by Canaccord Genuity, on November 13, is at Buy, with a price target of $218.00.
• Millendo Therapeutics, Inc. MLND shares decreased by 20.2% to $6.19. The market cap seems to be at $97.1 million.
• Omeros, Inc. OMER stock plummeted 11.2% to $13.54. The market cap seems to be at $784.4 million. The most recent rating by H.C. Wainwright, on December 02, is at Buy, with a price target of $34.00.
• Biocept, Inc. BIOC shares plummeted 9.7% to $0.53. The market cap stands at $16.4 million.
• Akers Biosciences, Inc. AKER stock plummeted 9.3% to $4.99. The market cap stands at $4.8 million.
• Avita Medical, Inc. RCEL shares decreased by 3.0% to $8.30. The market value of their outstanding shares is at $788.9 million.
• Ardelyx, Inc. ARDX shares fell 2.9% to $6.62. The market cap seems to be at $488.7 million. The most recent rating by SVB Leerink, on September 24, is at Outperform, with a price target of $9.00.
• Abeona Therapeutics, Inc. ABEO stock decreased by 1.0% to $2.96. The market value of their outstanding shares is at $120.9 million.